The recent report by Najean and Rain for the French Polycythemia Study Group1 comparing hydroxyurea with pipobroman in the treatment of polycythemia vera (PV) makes an important contribution to the debate about the treatment of this condition. We would like to make some observations about the presentation of their results. This particularly relates to their statements about the observed actuarial risk of leukemia. The investigators chose, both in the text and the summary, to state that for bo...Expand abstract
- Publication status:
- Publication date:
- Source identifiers:
- Local pid:
- Copyright date:
Leukemic transformation in polycythemia Vera. MPD(UK) Study Group.
If you are the owner of this record, you can report an update to it here: Report update to this record